News
SMDPY
15.90
NaN%
--
Sumitomo Pharma Co, Ltd. GAAP EPS of JPY 248.84, revenue of JPY 227.12B
Seeking Alpha · 10/31 16:25
Trump’s 100% drug tariffs send pharma stocks lower
Seeking Alpha · 09/26 08:59
Weekly Report: what happened at SMDPY last week (0908-0912)?
Weekly Report · 09/15 10:20
Weekly Report: what happened at SMDPY last week (0901-0905)?
Weekly Report · 09/08 10:22
Weekly Report: what happened at SMDPY last week (0825-0829)?
Weekly Report · 09/01 10:19
Weekly Report: what happened at SMDPY last week (0818-0822)?
Weekly Report · 08/25 10:25
Weekly Report: what happened at SMDPY last week (0811-0815)?
Weekly Report · 08/18 10:20
Weekly Report: what happened at SMDPY last week (0804-0808)?
Weekly Report · 08/11 10:24
Weekly Report: what happened at SMDPY last week (0728-0801)?
Weekly Report · 08/04 10:27
Sumitomo Pharma Co., Ltd. reports FQ1 results
Seeking Alpha · 07/31 14:23
Weekly Report: what happened at SMDPY last week (0721-0725)?
Weekly Report · 07/28 10:27
Weekly Report: what happened at SMDPY last week (0714-0718)?
Weekly Report · 07/21 10:20
Weekly Report: what happened at SMDPY last week (0707-0711)?
Weekly Report · 07/14 10:26
Weekly Report: what happened at SMDPY last week (0630-0704)?
Weekly Report · 07/07 10:21
Weekly Report: what happened at SMDPY last week (0623-0627)?
Weekly Report · 06/30 10:25
Weekly Report: what happened at SMDPY last week (0616-0620)?
Weekly Report · 06/23 10:21
Weekly Report: what happened at SMDPY last week (0609-0613)?
Weekly Report · 06/16 10:25
Weekly Report: what happened at SMDPY last week (0602-0606)?
Weekly Report · 06/09 10:26
Weekly Report: what happened at SMDPY last week (0526-0530)?
Weekly Report · 06/02 10:31
Weekly Report: what happened at SMDPY last week (0519-0523)?
Weekly Report · 05/26 10:30
More
Webull provides a variety of real-time SMDPY stock news. You can receive the latest news about Sumitomo Dainippon Pharma through multiple platforms. This information may help you make smarter investment decisions.
About SMDPY
Sumitomo Pharma Co Ltd is a Japan-based company mainly engaged in the pharmaceutical business. The Company operates through three geographical segments. The Japan segment is engaged in the manufacture, purchase, and sale of prescription drugs, purchase and sale of medical devices, undertakes development and manufacture in the field of regenerative medicine and cellular medicine, and the manufacture of pharmaceuticals, medical devices, and regenerative medicine products that have been developed through joint development in the field of regenerative medicine. This segment also provides storage and delivery service of pharmaceuticals. The North America segment is engaged in the manufacture, purchase, and sale of prescription drugs. The Asia segment is engaged in the manufacture and sale of prescription drugs (small packaging), and the import, purchase and sale of prescription drugs in Southeast Asia and Taiwan, as well as the provision and collection of information on products.